A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis

Phase 3 Not yet recruiting 500 enrolled CSPC Ouyi Pharmaceutical Co., Ltd.

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of different doses of SYHX1901 tablets in the treatment of moderate to severe plaque psoriasis.

Timeline

Start: 2025-06-01
Primary completion: 2027-04-28
Completion: 2027-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SYHX1901	Unknown	—	Oral

A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis

Summary

Timeline

Drugs

Indications